Page last updated: 2024-08-25

grepafloxacin and norfloxacin

grepafloxacin has been researched along with norfloxacin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's2 (20.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domagala, JM; Hagen, SE; Heifetz, CL; Johnson, J1
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H1
Cai, SH; Hasegawa, T; Kitaichi, K; Nadai, M; Takagi, K; Tatsumi, Y; Wang, L; Yoshizumi, H; Zhao, YL1
Morgan-Linnell, SK; Zechiedrich, L1
Larruskain, J; Montes, M; Orden, B; Perez-Trallero, E; Tamayo, E1
Brillault, J; Couet, W; De Castro, WV1
Blaskovich, MAT; Pham, TDM; Ziora, ZM1
Mitsuhashi, S; Wakebe, H1
Andrews, JM; Brenwald, N; Wise, R1
Frimpong, EK; Honda, T; Voravuthikunchai, SP; Yoh, M1

Reviews

1 review(s) available for grepafloxacin and norfloxacin

ArticleYear
Quinolone antibiotics.
    MedChemComm, 2019, Oct-01, Volume: 10, Issue:10

    Topics:

2019

Other Studies

9 other study(ies) available for grepafloxacin and norfloxacin

ArticleYear
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:3

    Topics: 4-Quinolones; Anti-Infective Agents; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Methylation; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

1991
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

    Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism

1999
Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:3

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Biliary Tract; Doxorubicin; Drug Resistance, Neoplasm; Fluoroquinolones; Leukemia P388; Male; Mice; Piperazines; Quinolones; Rats; Rats, Wistar; Tumor Cells, Cultured

2002
Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: DNA Topoisomerases; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Mutation

2007
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Prospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes

2010
Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Absorption; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport, Active; Cell Line; Cell Membrane Permeability; Cyclosporins; Diffusion; Drug Interactions; Drug Resistance, Bacterial; Epithelial Cells; Fluoroquinolones; Kinetics; Lipids; Lung

2010
Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:10

    Topics: Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus

1992
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:4

    Topics: Amoxicillin; Anti-Infective Agents; Bacteroides fragilis; Cefaclor; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Protein Binding; Quinolones; Staphylococcus

1993
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
    Canadian journal of microbiology, 1999, Volume: 45, Issue:9

    Topics: Animals; Anti-Infective Agents; Azithromycin; Bacterial Toxins; Chlorocebus aethiops; Clarithromycin; Dose-Response Relationship, Drug; Enterotoxins; Erythromycin; Escherichia coli O157; Fluoroquinolones; Humans; Macrolides; Norfloxacin; Piperazines; Quinolones; Shiga Toxin 1; Time Factors; Vero Cells

1999